Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.
| |
| |
| | Below is an important message from one of our valued partners along with today's top headlines. | | | |
| |
| FDA Approval Could Send This Stock Soaring - Ad
Whenever the FDA approves a new drug... Timely investors could see 300-400% returns... ChemoCentryx soared 281% in the year after it won FDA approval... Immunogen jumped 449% in the two years after it won FDA approval... Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did. Continue reading ➔ | | | | | | | Top 4 Stocks About to Reach Their 52-Week High - Ad
A 52-week high is a technical indicator used by some of the world's top traders and investors to determine the current and future value of a stock. In this report we reveal today's top 4 stocks about to reach their 52-week highs.
| | | | | | By clicking the link above you will automatically opt-in to receive emails from TrendAdvisor and agree to Privacy Policy | | | | | |
| Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.
2967 Dundas St. W. #990, Toronto, ON M6P 1Z2, 917.672.7040 © 2025 Musth | PriceActionEA | All rights reserved.
Unsubscribe | | | | |

0 Response to "FDA Approval Could Send This Stock Soaring"
Post a Comment